RE: Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer

被引：1
作者：
Bujko, Krzysztof [1 ]
Rutkowski, Andrzej [2 ]
机构：
[1] M Sklodowska Curie Mem Canc Ctr, Dept Radiotherapy, WK Roentgena 5, PL-02781 Warsaw, Poland
[2] M Sklodowska Curie Mem Canc Ctr, Dept Gastroenterol Oncol, Warsaw, Poland
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2016年 / 108卷 / 12期
关键词：
CHEMORADIATION; TRIAL;
D O I：
10.1093/jnci/djw291
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：1
相关论文
共 7 条
  • [1] High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study
    Appelt, Ane L.
    Ploen, John
    Harling, Henrik
    Jensen, Frank S.
    Jensen, Lars H.
    Jorgensen, Jens C. R.
    Lindebjerg, Jan
    Rafaelsen, Soren R.
    Jakobsen, Anders
    [J]. LANCET ONCOLOGY, 2015, 16 (08) : 919 - 927
  • [2] Long-course oxaliplatin-based preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study
    Bujko, K.
    Wyrwicz, L.
    Rutkowski, A.
    Malinowska, M.
    Pietrzak, L.
    Krynski, J.
    Michalski, W.
    Oledzki, J.
    Kusnierz, J.
    Zajac, L.
    Bednarczyk, M.
    Szczepkowski, M.
    Tarnowski, W.
    Kosakowska, E.
    Zwolinski, J.
    Winiarek, M.
    Wisniowska, K.
    Partycki, M.
    Beczkowska, K.
    Polkowski, W.
    Stylinski, R.
    Wierzbicki, R.
    Bury, P.
    Jankiewicz, M.
    Paprota, K.
    Lewicka, M.
    Cisel, B.
    Skorzewska, M.
    Mielko, J.
    Bebenek, M.
    Maciejczyk, A.
    Kapturkiewicz, B.
    Dybko, A.
    Hajac, L.
    Wojnar, A.
    Lesniak, T.
    Zygulska, J.
    Jantner, D.
    Chudyba, E.
    Zegarski, W.
    Las-Jankowska, M.
    Jankowski, M.
    Kolodziejski, L.
    Radkowski, A.
    Zelazowska-Omiotek, U.
    Czeremszynska, B.
    Kepka, L.
    Kolb-Sielecki, J.
    Toczko, Z.
    Fedorowicz, Z.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 (05) : 834 - 842
  • [3] Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trial
    Gerard, Jean-Pierre
    Chamorey, Emmanuel
    Gourgou-Bourgade, Sophie
    Benezery, Karene
    de Laroche, Guy
    Mahe, Marc-Andre
    Boige, Valerie
    Juzyna, Beata
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 (02) : 246 - 252
  • [4] Local Recurrence After Complete Clinical Response and Watch and Wait in Rectal Cancer After Neoadjuvant Chemoradiation: Impact of Salvage Therapy on Local Disease Control
    Habr-Gama, Angelita
    Gama-Rodrigues, Joaquim
    Sao Juliao, Guilherme P.
    Proscurshim, Igor
    Sabbagh, Charles
    Lynn, Patricio B.
    Perez, Rodrigo O.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (04): : 822 - 828
  • [5] Martens MH, 2016, JNCI-J NATL CANCER I, V108, P1
  • [6] Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer
    Pettersson, D.
    Cedermark, B.
    Holm, T.
    Radu, C.
    Pahlman, L.
    Glimelius, B.
    Martling, A.
    [J]. BRITISH JOURNAL OF SURGERY, 2010, 97 (04) : 580 - 587
  • [7] Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis
    Renehan, Andrew G.
    Malcomson, Lee
    Emsley, Richard
    Gollins, Simon
    Maw, Andrew
    Myint, Arthur Sun
    Rooney, Paul S.
    Susnerwala, Shabbir
    Blower, Anthony
    Saunders, Mark P.
    Wilson, Malcolm S.
    Scott, Nigel
    O'Dwyer, Sarah T.
    [J]. LANCET ONCOLOGY, 2016, 17 (02) : 174 - 183
1